The steady state pharmacokinetics of trientine in Wilson disease patients
- 7 February 2018
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 74 (6) , 731-736
Abstract
To determine the steady state pharmacokinetics of trientine in children (≥ 12 years of age) and adult patients who had been receiving trientine dihydrochloride therapy prior to the study.Keywords
This publication has 19 references indexed in Scilit:
- Wilson's disease and other neurological copper disordersThe Lancet Neurology, 2015
- A genetic study of Wilson’s disease in the United KingdomBrain, 2013
- Late-Onset Wilson’s DiseaseGastroenterology, 2007
- Wilson's diseaseThe Lancet, 2007
- Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort studyGut, 2006
- Identification and Analysis of Mutations in the Wilson Disease Gene (ATP7B): Population Frequencies, Genotype-Phenotype Correlation, and Functional AnalysesThe American Journal of Human Genetics, 1997
- The Wilson disease gene: spectrum of mutations and their consequencesNature Genetics, 1995
- The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease geneNature Genetics, 1993
- The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes geneNature Genetics, 1993
- PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVERBrain, 1912